Literature DB >> 20359175

Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution.

Debbie C Crans1, Boyan Zhang, Ernestas Gaidamauskas, Anastasios D Keramidas, Gail R Willsky, Chris R Roberts.   

Abstract

Although dogma states that vanadate is readily reduced by glutathione, cysteine, and other thiols, there are several examples documenting that vanadium(V)-sulfur complexes can form and be observed. This conundrum has impacted life scientists for more than two decades. Investigation of this problem requires an understanding of both the complexes that form from vanadium(IV) and (V) and a representative thiol in aqueous solution. The reactions of vanadate and hydrated vanadyl cation with 2-mercaptoethanol have been investigated using multinuclear NMR, electron paramagnetic resonance (EPR), and UV-vis spectroscopy. Vanadate forms a stable complex of 2:2 stoichiometry with 2-mercaptoethanol at neutral and alkaline pH. In contrast, vanadate can oxidize 2-mercaptoethanol; this process is favored at low pH and high solute concentrations. The complex that forms between aqueous vanadium(IV) and 2-mercaptoethanol has a 1:2 stoichiometry and can be observed at high pH and high 2-mercaptoethanol concentration. The solution structures have been deduced based on coordination induced chemical shifts and speciation diagrams prepared. This work demonstrates that both vanadium(IV) and (V)-thiol complexes form and that redox chemistry also takes place. Whether reduction of vanadate takes place is governed by a combination of parameters: pH, solute- and vanadate-concentrations and the presence of other complexing ligands. On the basis of these results it is now possible to understand the distribution of vanadium in oxidation states (IV) and (V) in the presence of glutathione, cysteine, and other thiols and begin to evaluate the forms of the vanadium compounds that exert a particular biological effect including the insulin-enhancing agents, antiamoebic agents, and interactions with vanadium binding proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359175      PMCID: PMC2884226          DOI: 10.1021/ic100080k

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  37 in total

Review 1.  The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds.

Authors:  Debbie C Crans; Jason J Smee; Ernestas Gaidamauskas; Luqin Yang
Journal:  Chem Rev       Date:  2004-02       Impact factor: 60.622

2.  A novel vanadium reductase, Vanabin2, forms a possible cascade involved in electron transfer.

Authors:  Norifumi Kawakami; Tatsuya Ueki; Yusuke Amata; Kan Kanamori; Koichi Matsuo; Kunihiko Gekko; Hitoshi Michibata
Journal:  Biochim Biophys Acta       Date:  2009-02-03

3.  Identification of Vanabin-interacting protein 1 (VIP1) from blood cells of the vanadium-rich ascidian Ascidia sydneiensis samea.

Authors:  Tatsuya Ueki; Koki Shintaku; Yuki Yonekawa; Nariaki Takatsu; Hiroshi Yamada; Toshiyuki Hamada; Hiroshi Hirota; Hitoshi Michibata
Journal:  Biochim Biophys Acta       Date:  2007-02-17

4.  Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate.

Authors:  G Huyer; S Liu; J Kelly; J Moffat; P Payette; B Kennedy; G Tsaprailis; M J Gresser; C Ramachandran
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

5.  Dioxo- and oxovanadium(V) complexes of thiohydrazone ONS donor ligands: synthesis, characterization, reactivity, and antiamoebic activity.

Authors:  Mannar R Maurya; Amit Kumar; Abdul R Bhat; Amir Azam; Cerstin Bader; Dieter Rehder
Journal:  Inorg Chem       Date:  2006-02-06       Impact factor: 5.165

6.  Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).

Authors:  H Sakurai; K Fujii; H Watanabe; H Tamura
Journal:  Biochem Biophys Res Commun       Date:  1995-09-25       Impact factor: 3.575

7.  Glutathione reduces cytoplasmic vanadate. Mechanism and physiological implications.

Authors:  I G Macara; K Kustin; L C Cantley
Journal:  Biochim Biophys Acta       Date:  1980-04-17

8.  Solid state and aqueous solution characterization of rectangular tetranuclear V(IV/V)-p-semiquinonate/hydroquinonate complexes exhibiting a proton induced electron transfer.

Authors:  Chryssoula Drouza; Anastasios D Keramidas
Journal:  Inorg Chem       Date:  2008-07-19       Impact factor: 5.165

9.  Identification of clusters from reactions of ruthenium arene anticancer complex with glutathione using nanoscale liquid chromatography Fourier transform ion cyclotron mass spectrometry combined with (18)O-labeling.

Authors:  Fuyi Wang; Stefan Weidt; Jingjing Xu; C Logan Mackay; Pat R R Langridge-Smith; Peter J Sadler
Journal:  J Am Soc Mass Spectrom       Date:  2007-12-15       Impact factor: 3.109

10.  Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato)oxovanadium (IV).

Authors:  Ming Li; Wenjun Ding; Bharat Baruah; Debbie C Crans; Ruilin Wang
Journal:  J Inorg Biochem       Date:  2008-06-20       Impact factor: 4.155

View more
  10 in total

1.  Vanadyl bisacetylacetonate protects β cells from palmitate-induced cell death through the unfolded protein response pathway.

Authors:  Zhonglan Gao; Chengyue Zhang; Siwang Yu; Xiaoda Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2011-04-22       Impact factor: 3.358

2.  Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.

Authors:  Manoj Saxena; Sergio A Loza-Rosas; Kavita Gaur; Shweta Sharma; Sofia C Pérez Otero; Arthur D Tinoco
Journal:  Coord Chem Rev       Date:  2018-03-20       Impact factor: 22.315

3.  Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes.

Authors:  Gail R Willsky; Lai-Har Chi; Michael Godzala; Paul J Kostyniak; Jason J Smee; Alejandro M Trujillo; Josephine A Alfano; Wenjin Ding; Zihua Hu; Debbie C Crans
Journal:  Coord Chem Rev       Date:  2011-10       Impact factor: 22.315

4.  Bioimaging Techniques Reveal Foliar Phosphate Uptake Pathways and Leaf Phosphorus Status.

Authors:  Maja Arsic; Stine Le Tougaard; Daniel Pergament Persson; Helle Juel Martens; Casey L Doolette; Enzo Lombi; Jan Kofod Schjoerring; Søren Husted
Journal:  Plant Physiol       Date:  2020-06-15       Impact factor: 8.340

Review 5.  Anticancer activity of metal complexes: involvement of redox processes.

Authors:  Ute Jungwirth; Christian R Kowol; Bernhard K Keppler; Christian G Hartinger; Walter Berger; Petra Heffeter
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

6.  First Steps Towards an Understanding of a Mode ofCarcinogenic Action for Vanadium Pentoxide.

Authors:  Detlef Schuler; Hans-Jörg Chevalier; Mandy Merker; Katja Morgenthal; Jean-Luc Ravanat; Peter Sagelsdorff; Marc Walter; Klaus Weber; Douglas McGregor
Journal:  J Toxicol Pathol       Date:  2011-10-12       Impact factor: 1.628

Review 7.  Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases.

Authors:  Jan Korbecki; Irena Baranowska-Bosiacka; Izabela Gutowska; Dariusz Chlubek
Journal:  Int J Mol Sci       Date:  2015-06-04       Impact factor: 5.923

8.  Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study.

Authors:  Aviva Levina; Andrew I McLeod; Anna Pulte; Jade B Aitken; Peter A Lay
Journal:  Inorg Chem       Date:  2015-04-23       Impact factor: 5.165

9.  Decavanadate Inhibits Mycobacterial Growth More Potently Than Other Oxovanadates.

Authors:  Nuttaporn Samart; Zeyad Arhouma; Santosh Kumar; Heide A Murakami; Dean C Crick; Debbie C Crans
Journal:  Front Chem       Date:  2018-11-20       Impact factor: 5.221

Review 10.  On the Capability of Oxidovanadium(IV) Derivatives to Act as All-Around Catalytic Promoters Since the Prebiotic World.

Authors:  Patrizio Campitelli; Marcello Crucianelli
Journal:  Molecules       Date:  2020-07-06       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.